Seminars in Pediatric Surgery
Volume 17, Issue 1 , Pages 42-52 , February 2008

Respiratory infections: Pneumonia, lung abscess, and empyema

  • Pramod S. Puligandla, MD, MSc, FRCSC, FACS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Pramod S. Puligandla, MD, MSc, FRCSC, FACS, McGill University, Pediatric Surgery and Pediatric Critical Care Medicine, The Montreal Children’s Hospital, Room C1129, 2300 Tupper Street, Montréal, Québec, Canada, H3H 1P3.
    • ,
  • Jean-Martin Laberge, MD, FRCSC, FACS

References 

  1. Bhutta ZA. Dealing with childhood pneumonia in developing countries: how can we make a difference?. Arch Dis Child. 2007;92:286–288
  2. Wardlaw T, Salama P, Johansson EW, et al. Pneumonia: the leading killer of children. Lancet. 2006;368:1048–1050
  3. Colin AA. Pneumonia in the developed world. Paediatr Respir Rev. 2006;7(suppl 1):S138–S140
  4. Tan TQ, Mason EO, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110:1–6
  5. English M. Impact of bacterial pneumonias on world child health. Paediatr Respir Rev. 2000;1:21–25
  6. Hale KA, Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev. 2006;7:145–151
  7. Chiou CC, Yu VL. Severe pneumococcal pneumonia: new strategies for management. Curr Opin Crit Care. 2006;12:470–476
  8. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–437
  9. Murray DL, Gilsdorf JR. Chemoprophylaxis for household contacts of index cases of invasive non-type b Haemophilus influenzae disease. Pediatr Infect Dis J. 2001;20:1099–1100
  10. Correa AG, Starke JR. Bacterial pneumonias. In:  Chernick V,  Boat TF editor. Kendig’s Disorders of the Respiratory Tract in Children. Philadelphia, PA: W.B. Saunders Company; 1998;
  11. Laberge JM, Puligandla P, Flageole H. Asymptomatic congenital lung malformations. Semin Pediatr Surg. 2005;14:16–33
  12. Nelson CT. Mycoplasma and Chlamydia pneumonia in pediatrics. Semin Respir Infect. 2002;17:10–14
  13. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol. 1994;32:903–905
  14. Corsaro D, Valassina M, Venditti D, et al. Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections. Diagn Microbiol Infect Dis. 1999;35:105–108
  15. Donald PR. Childhood tuberculosis. Curr Opin Pulm Med. 2000;6:187–192
  16. Donald PR. Preventing tuberculosis in childhood. Indian J Pediatr. 2000;67:383–385
  17. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States (Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America). MMWR Recomm Rep. 2005;54:1–81
  18. Inselman MD, Kendig EL. Tuberculosis. In:  Chernick V,  Boat TF editor. Kendig’s Disorders of the Respiratory Tract in Children. Philadelphia, PA: W.B. Saunders Company; 1998;
  19. Lodha R, Kabra SK. Newer diagnostic modalities for tuberculosis. Indian J Pediatr. 2004;71:221–227
  20. Enarson DA. Use of the tuberculin skin test in children. Paediatr Respir Rev. 2004;5(suppl A):S135–S137
  21. Hewitson JP, Von Oppell UO. Role of thoracic surgery for childhood tuberculosis. World J Surg. 1997;21:468–474
  22. Freixinet J. Surgical indications for treatment of pulmonary tuberculosis. World J Surg. 1997;21:475–479
  23. Jones D, Havlir DV. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med. 2002;23:665–674
  24. Griffith DE. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:810–812
  25. Han D, Lee KS, Koh WJ, et al. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. AJR Am J Roentgenol. 2003;181:513–517
  26. Brown-Elliott BA, Griffith DE, Wallace RJ. Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med. 2002;22:911–925
  27. Puligandla PS, Laberge JM. Infections and diseases of the lungs, pleura, and mediastinum. In:  Grosfeld JL,  O’Neill JA,  Coran AG AG, et al. editor. Pediatric Surgery. Philadelphia, PA: Mosby; 2006;
  28. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006;368:312–322
  29. Lowther SA, Shay DK, Holman RC, et al. Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J. 2000;19:11–17
  30. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2004;158:119–126
  31. Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2000;CD001266
  32. Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2004;CD003123
  33. Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;CD004878
  34. Davison C, Ventre KM, Luchetti M, et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med. 2004;5:482–489
  35. Kamal-Bahl S, Doshi J, Campbell J. Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review. Arch Pediatr Adolesc Med. 2002;156:1034–1041
  36. Hamelin ME, Boivin G. Human metapneumovirus: a ubiquitous and long-standing respiratory pathogen. Pediatr Infect Dis J. 2005;24:S203–S207
  37. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719–724
  38. Boivin G, De SG, Cote S, et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis. 2003;9:634–640
  39. Semple MG, Cowell A, Dove W, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191:382–386
  40. Cote S, Abed Y, Boivin G. Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol. 2003;41:3631–3635
  41. Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev. 2006;19:546–557
  42. Neville K, Renbarger J, Dreyer Z. Pneumonia in the immunocompromised pediatric cancer patient. Semin Respir Infect. 2002;17:21–32
  43. Waite S, Jeudy J, White CS. Acute lung infections in normal and immunocompromised hosts. Radiol Clin North Am. 2006;44:295–315
  44. Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003;4:595–604
  45. Pizzo PA, Rubin M, Freifeld A, et al. The child with cancer and infection (I. Empiric therapy for fever and neutropenia, and preventive strategies). J Pediatr. 1991;119:679–694
  46. Lehrnbecher T, Groll AH, Chanock SJ. Treatment of fungal infections in neutropenic children. Curr Opin Pediatr. 1999;11:47–55
  47. Collin BA, Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am. 1998;12:781–805
  48. Aisner J, Schimpff SC, Bennett JE, et al. Aspergillus infections in cancer patients (Association with fireproofing materials in a new hospital). J Am Med Assoc. 1976;235:411–412
  49. Bergen GA, Shelhamer JH. Pulmonary infiltrates in the cancer patient (New approaches to an old problem). Infect Dis Clin North Am. 1996;10:297–325
  50. Choi YH, Leung AN. Radiologic findings: pulmonary infections after bone marrow transplantation. J Thorac Imaging. 1999;14:201–206
  51. Pizzo PA, Walsh TJ. Fungal infections in the pediatric cancer patient. Semin Oncol. 1990;17:6–9
  52. Heurlin N, Bergstrom SE, Winiarski J, et al. Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantation. Acta Paediatr. 1996;85:168–172
  53. Blyth CC, Palasanthiran P, O’Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics. 2007;119:772–784
  54. Meyers JD, McGuffin RW, Bryson YJ, et al. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis. 1982;146:80–84
  55. van der Meer JT, Drew WL, Bowden RA, et al. Summary of the International Consensus Symposium on Advances in the Diagnosis (Treatment and Prophylaxis and Cytomegalovirus Infection). Antiviral Res. 1996;32:119–140
  56. Pizzo PA. Infectious complications in the child with cancer (II. Management of specific infectious organisms). J Pediatr. 1981;98:513–523
  57. Hughes WT. Pneumocystis carinii pneumonitis. N Engl J Med. 1987;317:1021–1023
  58. Perez MS, Van Dyke RB. Pulmonary infections in children with HIV infection. Semin Respir Infect. 2002;17:33–46
  59. Graham SM. Impact of HIV on childhood respiratory illness: differences between developing and developed countries. Pediatr Pulmonol. 2003;36:462–468
  60. The CASCADE Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection (Concerted Action on SeroConversion to AIDS and Death in Europe). Lancet. 2000;355:1158–1159
  61. Mofenson LM, Yogev R, Korelitz J, et al. Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk (National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group). Pediatr Infect Dis J. 1998;17:872–880
  62. Simonds RJ, Orejas G. Pneumocystis carinii pneumonia and toxoplasmosis. In:  Pizzo PA,  Wilfert C editor. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. Baltimore, MD: Williams & Wilkins; 1998;
  63. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus (National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention). MMWR Recomm Rep. 1995;44:1–11
  64. Schneider MM, Borleffs JC, Stolk RP, et al. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet. 1999;353:201–203
  65. Sanchez JM, Ramos Amador JT, Fernandez de MS, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2003;22:863–867
  66. The role of BCG vaccine in the prevention and control of tuberculosis in the United States (A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices). MMWR Recomm Rep. 1996;45:1–18
  67. Prendergast A, Tudor-Williams G, Jeena P, et al. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet. 2007;370:68–80
  68. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Pediatrics. 1998;102:999–1085
  69. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Recomm Rep. 1999;48:1–6
  70. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel (International AIDS Society-USA). Arch Intern Med. 1998;158:957–969
  71. Shenep JL, Flynn PM. Pulmonary fungal infections in immunocompromised children. Curr Opin Pediatr. 1997;9:213–218
  72. Patradoon-Ho P, Fitzgerald DA. Lung abscess in children. Paediatr Respir Rev. 2007;8:77–84
  73. Tan TQ, Seilheimer DK, Kaplan SL. Pediatric lung abscess: clinical management and outcome. Pediatr Infect Dis J. 1995;14:51–55
  74. Hoffer FA, Bloom DA, Colin AA, et al. Lung abscess versus necrotizing pneumonia: implications for interventional therapy. Pediatr Radiol. 1999;29:87–91
  75. Yen CC, Tang RB, Chen SJ, et al. Pediatric lung abscess: a retrospective review of 23 cases. J Microbiol Immunol Infect. 2004;37:45–49
  76. Avansino JR, Goldman B, Sawin RS, et al. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics. 2005;115:1652–1659
  77. Sonnappa S, Jaffe A. Treatment approaches for empyema in children. Paediatr Respir Rev. 2007;8:164–170
  78. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221–227
  79. Finck C, Wagner C, Jackson R, et al. Empyema: development of a critical pathway. Semin Pediatr Surg. 2002;11:25–28
  80. Fuller MK, Helmrath MA. Thoracic empyema, application of video-assisted thoracic surgery and its current management. Curr Opin Pediatr. 2007;19:328–332

PII: S1055-8586(07)00072-8

doi: 10.1053/j.sempedsurg.2007.10.007

Seminars in Pediatric Surgery
Volume 17, Issue 1 , Pages 42-52 , February 2008

Article Tools

* Image Usage & Resolution